| Ms Teresa Lysha Bridges, LCSW | |
|
8400 Nw 36th St, Coral Springs, FL 33065-4503 | |
| (786) 488-7233 | |
| Not Available |
| Full Name | Ms Teresa Lysha Bridges |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 8400 Nw 36th St, Coral Springs, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093566705 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | SW22617 (Florida) | Secondary |
| 1041C0700X | Social Worker - Clinical | SW22617 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Teresa Lysha Bridges, LCSW 2139 N University Dr # 5308, Coral Springs, FL 33071-6134 Ph: (786) 488-7233 | Ms Teresa Lysha Bridges, LCSW 8400 Nw 36th St, Coral Springs, FL 33065-4503 Ph: (786) 488-7233 |
News Archive
​Dermatology researcher Nicole Ward, PhD, has earned her third National Institutes of Health grant in a year - including two that scored in the first percentile. With this most recent award, an R21, she will investigate the role the nervous system plays in psoriasis - an inflammatory autoimmune disease characterized by raised areas of red, scaly, itchy and sometimes painful patches of skin.
The Global Network for Neglected Tropical Diseases' "End the Neglect" blog reports that the Dengue Vaccine Initiative has launched a redesigned website, including a new blog that "will include regular posts about the disease, dengue in the news, the work of DVI and the development of a dengue vaccine."
An international team of ecologists has identified the bat species with the greatest potential to harbor filoviruses-a family that includes Ebola virus.
Visits to the ER are not always for true medical emergencies - and some policymakers have been fighting the problem by denying or limiting payments if the patient's diagnosis upon discharge is for "nonemergency" conditions.
Researchers at Imperial College London have identified a new appetite suppressant for promoting weight loss that they say works in rodents and may one day be used to develop an effective anti-obesity treatment. Results of the new study were presented at The Endocrine Society's 91st Annual Meeting in Washington, D.C.
› Verified 1 days ago